Dupont Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Dupont Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-41,419	Closed	-$170K	–	1933
2022 Q1	$170K	Sell	41,419 -3,663	-8%	-$13.3K	0.01%	1117
2021 Q4	$161K	Sell	45,082 -17,975	-29%	-$62.9K	0.01%	1191
2021 Q3	$230K	Sell	63,057 -8,913	-12%	-$36K	0.01%	1191
2021 Q2	$314K	Hold	71,970	–	–	0.01%	1185
2021 Q1	$296K	Sell	71,970 -14,760	-17%	-$64K	0.01%	1150
2020 Q4	$346K	Sell	86,730 -53,587	-38%	-$173K	0.01%	991
2020 Q3	$379K	Sell	140,317 -9,398	-6%	-$26K	0.01%	891
2020 Q2	$412K	Buy	+149,715	New	+$418K	0.01%	858

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Dupont Capital Management's ATRS Position: Q2 2022 in Review

Dupont Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 41,419 shares — an estimated $170K sold.

Dupont Capital Management first reported a position in ATRS in Q2 2020 and held it in 8 quarters. The position peaked at $412K in Q2 2020. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Dupont Capital Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Dupont Capital Management sold 41,419 Antares Pharma, Inc. shares in Q2 2022, an estimated $170K.
Dupont Capital Management first reported a position in Antares Pharma, Inc. in Q2 2020 and held it in 8 quarters.
Dupont Capital Management's Antares Pharma, Inc. position peaked at $412K in Q2 2020.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Dupont Capital Management's 13F filing for Q2 2022, filed 26 Jul 2022.